About US
Contact us
-
U.K. drug costs drop as blockbusters go off patentOn the heels of news that drug spending in the U.S. rose last year, in part because of new branded drugs, the U.K. reports a decline in its pharma costs, thanks to blockbuster medications that lost pa2012/4/9
-
Pfizer shrinks worker severance packagesPfizer ($PFE) CEO Ian Read has vowed to cut $1 billion in operating expenses at the drugmaker this year, and one way he plans to do that appears to be by reducing severance packages, Bloomberg reports2012/4/9
-
'Animal rule' allowed for J&J drug backed for new approvalJohnson & Johnson ($JNJ) has entered some atypical regulatory terrain. FDA advisors have heartily backed approval for the drug giant's antibiotic Levaquin for a new use that the federal government2012/4/6
-
Vaccines group in HPV price talks with Merck, GSKThe global vaccines group GAVI Alliance is nearing a deal to add vaccines against humanpapillomavirus, which can cause cervical cancer, to its offerings. The group says it's negotiating cut-rate price2012/4/6
-
FDA battling White House over politicization of regulationAfter operating on a very short leash during the Bush administration, many FDA staffers thought that a newera of independence from political forces at the White House was upon them when President Bara2012/4/5
-
IOM gives FDA to-do list for securing global drug suppliesU.S. regulators can't go solo on securing the U.S. drug supply. Nor can the FDA afford to count on agencies in developing nations, where counterfeiting abounds and unscrupulous manufacturers cut corne2012/4/5
-
Why Do You Need a Medical Malpractice Attorney?MIAMI, FL, March 30, 2012 /24-7PressRelease/ -- If you suspect that you or a loved one has been hurt by a doctor's error, why would you want to handle the case yourself? The medical issues alone are l2012/4/1
-
North Carolina considers drug liability protectionsNorth Carolina is sizing up proposed legislation that would be second only to Michigan's in throwing up legal hurdles for consumers who want to sue drugmakers for alleged harm from their products. The2012/4/1
-
Lawsuits against Pfizer's Celebrex, Bextra get class action statusPfizer has been sent to class. A judge has decided that lawsuits against Pfizer ($PFE) over the outlook for pain-relief drugsCelebrex and Bextra can be pursued together. Shareholders have sued, claim2012/3/31
-
Bayer gets positive ruling from NICE on XareltoThe U.K.'s NICE has recommended Bayer HealthCare's ($BAY)Xarelto for stroke and embolisms in draft guidance. Final guidance may come in April. NICE originally ruled against the drug but requested add2012/3/31